These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9169966)

  • 61. Moxonidine and cognitive function: interactions with moclobemide and lorazepam.
    Wesnes K; Simpson PM; Jansson B; Grahnén A; Weimann HJ; Küppers H
    Eur J Clin Pharmacol; 1997; 52(5):351-8. PubMed ID: 9272403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam.
    Agelink MW; Majewski TB; Andrich J; Mueck-Weymann M
    Crit Care Med; 2002 May; 30(5):997-1006. PubMed ID: 12006794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxiety.
    Diaper A; Papadopoulos A; Rich AS; Dawson GR; Dourish CT; Nutt DJ; Bailey JE
    Hum Psychopharmacol; 2012 Nov; 27(6):540-8. PubMed ID: 23027657
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A double-dissociation of behavioural and event-related potential effects of two benzodiazepines with similar potencies.
    Pompéia S; Bueno OF; Lucchesi LM; Manzano GM; Galduróz JC; Tufik S
    J Psychopharmacol; 2000; 14(3):288-98. PubMed ID: 11106311
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative pharmacodynamics of benzodiazepines.
    Ellinwood EH; Nikaido AM; Heatherly DG
    Psychopharmacol Ser; 1987; 3():77-82. PubMed ID: 2881294
    [No Abstract]   [Full Text] [Related]  

  • 67. Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice.
    Burke TF; Miller LG; Moerschbaecher JM
    Pharmacol Biochem Behav; 1994 May; 48(1):69-76. PubMed ID: 7913233
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.
    File SE
    Psychopharmacology (Berl); 1982; 77(3):284-8. PubMed ID: 6126909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring.
    Riba J; Rodríguez-Fornells A; Münte TF; Barbanoj MJ
    Brain Res Cogn Brain Res; 2005 Oct; 25(2):554-65. PubMed ID: 16168630
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam.
    Yasui N; Kondo T; Otani K; Furukori H; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
    Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of alprazolam treatment on anxiety-like behavior induced by color stimulation in adult zebrafish.
    Pieróg M; Guz L; Doboszewska U; Poleszak E; Wlaź P
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():297-306. PubMed ID: 28867392
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lorazepam-induced effects on silent period and corticomotor excitability.
    Kimiskidis VK; Papagiannopoulos S; Kazis DA; Sotirakoglou K; Vasiliadis G; Zara F; Kazis A; Mills KR
    Exp Brain Res; 2006 Sep; 173(4):603-11. PubMed ID: 16525803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relations between emotion and conscious recollection of true and false autobiographical memories: an investigation using lorazepam as a pharmacological tool.
    Pernot-Marino E; Danion JM; Hedelin G
    Psychopharmacology (Berl); 2004 Aug; 175(1):60-7. PubMed ID: 15007596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alprazolam in end-stage renal disease. II. Pharmacodynamics.
    Schmith VD; Piraino B; Smith RB; Kroboth PD
    Clin Pharmacol Ther; 1992 May; 51(5):533-40. PubMed ID: 1587068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparative study on the clinical effects of flunitrazepam and lorazepam.
    Mansikka M; Kangas L; Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):320-1. PubMed ID: 6107279
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute and delayed effects of alprazolam on flight phobics during exposure.
    Wilhelm FH; Roth WT
    Behav Res Ther; 1997 Sep; 35(9):831-41. PubMed ID: 9299803
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
    Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The behavioural effects of lorazepam are poorly related to its concentration in the brain.
    Lister RG; File SE; Greenblatt DJ
    Life Sci; 1983 Apr; 32(17):2033-40. PubMed ID: 6132319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.